CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Share data	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Revenues	$ 217	$ 264	$ 264	$ 326
Cost of revenue	96	114	100	114
Gross profit	121	150	164	212
Operating expenses
Selling, general and administrative	2,214	2,386	4,412	5,213
Research and development cost	324	517	764	913
Operating Expenses, Total	2,538	2,903	5,176	6,126
Operating loss	(2,417)	(2,753)	(5,012)	(5,914)
Interest and other income/(expense), net	11	34	32	27
Gain on sale of loan receivable - related party			81	0
Net loss before income tax benefit	(2,406)	(2,719)	(4,899)	(5,887)
Income tax benefit/(expense)	51	(3)	51	167
Net loss from continuing operations before non-controlling interest			(4,848)	(5,720)
Discontinued operations
Net loss from operations of Medicexchange, net of income tax benefit			0	(234)
Gain on sale of Medicexchange, net of income taxes			0	149
Income (Loss) from Operations before Extraordinary Items, Total			0	(85)
Net loss before non-controlling interest	(2,355)	(2,722)	(4,848)	(5,805)
Net loss attributable to non-controlling interest	905	836	1,906	1,785
Net loss attributable to MGT Capital Investments, Inc.	$ (1,450)	$ (1,886)	$ (2,942)	$ (4,020)
Per share data:
Basic and diluted loss per share from continuing operations (in dollars per share)	$ (0.04)	$ (0.06)	$ (0.07)	$ (0.11)
Basic and diluted loss per share from discontinued operations (in dollars per share)			$ 0	$ (0.01)
Earnings Per Share, Basic and Diluted (in dollars per share)	$ (0.04)	$ (0.06)	$ (0.07)	$ (0.12)
Weighted average number of common shares outstanding (in shares)	39,050,590	32,550,590	39,448,941	32,550,590